Andrei Floroiu
2021
In 2021, Andrei Floroiu earned a total compensation of $2.4M as President and Chief Executive Officer at Biota Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,333 |
|---|---|
| Option Awards | $1,735,950 |
| Salary | $466,667 |
| Other | $9,225 |
| Total | $2,410,175 |
Floroiu received $1.7M in option awards, accounting for 72% of the total pay in 2021.
Floroiu also received $198.3K in non-equity incentive plan, $466.7K in salary and $9.2K in other compensation.
Rankings
In 2021, Andrei Floroiu's compensation ranked 5,297th out of 12,415 executives tracked by ExecPay. In other words, Floroiu earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,297 out of 12,415 | 57th |
Division Manufacturing | 2,231 out of 5,505 | 60th |
Major group Chemicals And Allied Products | 971 out of 2,375 | 59th |
Industry group Drugs | 865 out of 2,096 | 59th |
Industry Biological Products, Except Diagnostic Substances | 211 out of 449 | 53rd |
Source: SEC filing on April 28, 2023.
Floroiu's colleagues
We found two more compensation records of executives who worked with Andrei Floroiu at Biota Pharmaceuticals in 2021.